Cronkhite-Canada syndrome is a rare gastrointestinal disorder characterized by widespread colon polyps, unhealthy looking (dystrophic) nails, hair loss. Cronkhite-Canada syndrome (CCS) is a rare gastrointestinal (GI) polyposis syndrome characterized by the association of non-hereditary GI polyposis with the. Cronkhite-Canada Syndrome (CCS) is a rare non-inherited disease characterized by gastrointestinal polyposis and ectodermal abnormalities.

Author: Mijin Vudorr
Country: Germany
Language: English (Spanish)
Genre: Marketing
Published (Last): 25 January 2004
Pages: 440
PDF File Size: 11.78 Mb
ePub File Size: 17.23 Mb
ISBN: 820-9-72835-195-7
Downloads: 8336
Price: Free* [*Free Regsitration Required]
Uploader: Baran

It is characterized by acquired gastrointestinal polyposis with an associated ectodermal triad, including alopecia, onchodystrophy, and hyperpigmentation.

Worldwide, over cases have been reported in the past 50 years, primarily in Japan but also in the United States and other countries. Adenocarcinoma Pancreatic ductal carcinoma cystic neoplasms: Stool testing was positive for C difficile, syndgome oral vancomycin was initiated with satisfactory clinical response.

The symptoms of Cronkhite-Canada syndrome occur because of multiple polyps occurring in the stomach, small intestine, colon and, less frequently, the esophagus. Case reports have suggested the use of immunosuppressive treatment, including aziathioprin and ciclosporin, if other treatments are not effective.

Disease complications are typically secondary to severe malnutrition, malignancy, GI bleeding, and infection.

The most common presenting symptoms include hypogeusia Optimal cancer screening protocols have not been developed for CCS patients, owing to the rarity of the disease. Summary and related texts. Years Published,canqda, The diagnosis of CCS is clinicopathological and remains cqnada.

Where native canads surface epithelium remained, it showed a mild increase of intraepithelial lymphocytes and an occasional intraepithelial eosinophil. For information about clinical trials sponsored by private sources, in the main, contact: Pain management may also be required. Taylor1 J. For all other comments, please send your remarks via contact us. Management and treatment Current treatments, which can be used individually or in combination, include steroids, nutritional therapy fluid, electrolyte, protein and vitamin supplementation and, if necessary, an elemental diet or parenteral nutrition5-aminosalicylate acid, histamine H2 receptor antagonists, anti-tumor necrosis factor alpha agents, immunomodulators, and eradication of Helicobacter pylori.


Cronkhite-Canada Syndrome: Sustained Clinical Response with Anti-TNF Therapy

A case of Cronkhite-Canada syndrome presenting with adenomatous and inflammatory colon polyps. Nat Rev Gastroenterol Hepatol. The etiology of CCS is unknown, although evidence continues to emerge supporting an autoimmune basis. Laboratory parameters reveal normocytic, normochromic anemia, vitamin deficiency, hypoproteinemia and hypoalbuminemia. The abdomen was scaphoid and nontender with no hepatosplenomegaly. Cronkhite—Canada syndrome is a rare, sporadic, non-inherited disorder characterised by gastrointestinal and dermatological symptoms.

The classic CCS dermatological triad includes alopecia, skin hyperpigmentation, and onychodystrophy. Diagnostic methods Diagnosis relies on clinico-pathological features with the correlating cutaneous, radiological, endoscopic and pathological findings. The diagnostic criteria for Cronkhite Canada Syndrome is based on symptoms and particular features; however, there is no specific diagnostic test for this syndrome.

Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. Recent findings have called this hypothesis into question; specifically, the hair and nail changes may not improve with improved nutrition. Several months into steroid taper, the patient developed polyuria, polydipsia, and hyperglycemia which had not been present at higher steroid doses.

Cronkhite–Canada syndrome

No known genetic link; considered nonhereditary May represent an autoimmune disorder Digestion ; Pharmacological management of Cronkhite-Canada syndrome. Treatments proposed include cromolyn sodium and prednisone. The exact cause of Cronkhite-Canada syndrome is unknown. No cervical, inguinal, or axillary lymphadenopathy was identified.

Besides the GI tract, findings in the skin are also diagnostic for this disease.

Retrieved from ” https: General Discussion Cronkhite-Canada syndrome CCS is an extremely rare disease characterized by various intestinal polyps, loss of taste, hair loss, and nail growth problems.

Because there is no cure for Cronkhite—Canada syndrometreatment is symptomatic. Azathioprine has shown utility in maintaining remission of disease in 5 patients, with a median remission period of 4. Springer International Publishing, pp. It is a disease of middle age with an average age of diagnosis in the early 60s, and it is more common in males 3: Summary Epidemiology To date, there have been more than cases reported worldwide. Further prospective studies are needed to assess the effectiveness of steroid-sparing treatment given the superior side effect profile of these agents compared with high-dose glucocorticoid therapy.


Additionally, serology commonly shows antinuclear antibody positivity [ 10 ].

This section is empty. The patient also noticed onycholysis in both his hands and feet Figure 1followed by hyperpigmentation of his hands Figure 2soles of his feet and legs, and abdomen. There has been no evidence of gastrointestinal or colorectal cancer thus far. One test that can be positive with this syndrome is IgG4 plasma cells but a negative test does not rule out the syndrome.

Click here for information on linking to synrrome website or using our content or images. Other conditions consisting of multiple hamartomatous polyps of the digestive tract include Peutz-Jeghers syndromejuvenile polyposisand Cowden disease. Typically, the age of onset is during the middle years or old age.

Autoantibodies, including antinuclear antibody, antineutrophil cytoplasmic antibody, and rheumatoid factor RF were undetectable as were serologic tests for HIV, hepatitis, syphilis, and Lyme disease. The clinical course of CCS is progressive with occasional cron,hite remissions and frequent relapses, and with rare progression to malignancy. However, they may recur or be too numerous to remove individually.